Genmab A/SGMABNASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank71
3Y CAGR-17.3%
5Y CAGR-8.3%
Year-over-Year Change
Diluted earnings per share
3Y CAGR
-17.3%/yr
vs +36.6%/yr prior
5Y CAGR
-8.3%/yr
Recent deceleration
Acceleration
-53.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 4.67 | -61.5% |
| 2024 | 12.14 | +83.9% |
| 2023 | 6.60 | -20.1% |
| 2022 | 8.26 | +84.4% |
| 2021 | 4.48 | -38.0% |
| 2020 | 7.22 | +112.4% |
| 2019 | 3.40 | +43.5% |
| 2018 | 2.37 | +33.1% |
| 2017 | 1.78 | -7.3% |
| 2016 | 1.92 | - |